Technology‑Enabled Screening
Technology-supported prioritisation, duplicate detection and efficient literature review
About Us
One group. Four specialised divisions.
Bpharma
Site Management Organisation
Bpharma
Clinical Operations
Bpharma
Regulatory strategy, licensing & lifecycle
Bpharma
Pharmacovigilance

Bpharma combines technology-enabled literature screening with pharmacovigilance expertise to identify, assess and manage safety information from global scientific publications, supporting regulatory compliance and patient safety.
Technology-Supported Screening. Reliable Safety Insights.
Overview
In detail
Technology-supported prioritisation, duplicate detection and efficient literature review
Identification of Individual Case Safety Reports (ICSRs), signal evaluation and aggregate report support
Full-text retrieval, scientific assessment and translation support
Structured safety information transfer into global PV workflows

More detail
Bpharma provides country-specific literature monitoring through qualified local PV experts, so that relevant safety information from national publications is identified, assessed and integrated into your global pharmacovigilance system.
Monitoring of relevant local journals and national scientific publications
Screening by professionals familiar with local medical terminology
Identification and assessment of potential reportable safety cases
Screening strategies adapted to applicable country-specific PV requirements
Documented screening outcomes, quality oversight and inspection readiness
Timely transfer of relevant safety information to global PV teams
Process
Local route: local journals · native-language screening · safety assessment · global PV system. Local scientific knowledge connected to global safety oversight.